Interleukin-22 Suppresses the Growth of A498 Renal Cell Carcinoma Cells via Regulation of STAT1 Pathway

Interleukin-22 genetic polymorphisms and risk of colon cancer

(2010) Cheryl L. Thompson et al.   CANCER CAUSES & CONTROL

Interleukin-22 is a negative regulator of the allergic response

(2010) Bruno Schnyder et al.   CYTOKINE

Natural killer receptors: the burden of a name: Figure 1.

(2010) Henrique Veiga-Fernandes et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Association of Genetic Polymorphisms in STAT1 Gene with Increased Risk of Hepatocellular Carcinoma

(2010) Zhong-Zheng Zhu et al.   ONCOLOGY

High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C viruses

(2010) Juan F Arias et al.   Retrovirology

Differentiation, Distribution and γδ T Cell-Driven Regulation of IL-22-Producing T Cells in Tuberculosis

(2010) Shuyu Yao et al.   PLoS Pathogens

Renal cancer surgery in the elderly

(2009) Frederik C Roos et al.   CURRENT OPINION IN UROLOGY

Tumour cell survival signalling by the ERK1/2 pathway

(2008) K Balmanno et al.   CELL DEATH AND DIFFERENTIATION

Antiapoptotic Activity of Autocrine Interleukin-22 and Therapeutic Effects of Interleukin-22-Small Interfering RNA on Human Lung Cancer Xenografts

(2008) W. Zhang et al.   CLINICAL CANCER RESEARCH

Epidemiology, Clinical Staging, and Presentation of Renal Cell Carcinoma

(2008) G. Joel DeCastro et al.   UROLOGIC CLINICS OF NORTH AMERICA